• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钙离子/钙调蛋白依赖性蛋白激酶IIγ增强肺癌细胞的干细胞样特性和致瘤性。

Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.

作者信息

Chai Shoujie, Xu Xia, Wang Yongfang, Zhou You, Zhang Chenchen, Yang Yiming, Yang Ying, Xu Haiyan, Xu Rongzhen, Wang Kai

机构信息

Department of Respiratory Medicine, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Department of Hematology, Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

出版信息

Oncotarget. 2015 Jun 30;6(18):16069-83. doi: 10.18632/oncotarget.3866.

DOI:10.18632/oncotarget.3866
PMID:25965829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4599257/
Abstract

Highly tumorigenic stem-like cells, considered tumor-initiating cells (TICs), are the main cause of lung cancer initiation, relapse, and drug resistance. In this study, we identified that Ca2+/calmodulin-dependent protein kinase IIγ (CaMKIIγ) was aberrantly expressed in highly tumorigenic stem-like lung cancer cells, and was also correlated with poor prognosis in human lung cancer. Functionally, CaMKIIγ enhanced stem-like traits and the tumorigenicity of lung cancer cells in an Akt- and β-catenin-dependent manner. In addition, we found that CaMKIIγ upregulated Oct4 expression via Akt-mediated histone acetylation. Taken together, our findings reveal a critical role of CaMKIIγ in regulating the stemness and tumorigenicity of lung cancer cells and offer a promising therapeutic target for TICs.

摘要

具有高度致瘤性的干细胞样细胞,被认为是肿瘤起始细胞(TICs),是肺癌发生、复发和耐药的主要原因。在本研究中,我们发现Ca2+/钙调蛋白依赖性蛋白激酶IIγ(CaMKIIγ)在具有高度致瘤性的肺癌干细胞样细胞中异常表达,并且与人类肺癌的不良预后相关。在功能上,CaMKIIγ以Akt和β-连环蛋白依赖性方式增强肺癌细胞的干细胞样特性和致瘤性。此外,我们发现CaMKIIγ通过Akt介导的组蛋白乙酰化上调Oct4表达。综上所述,我们的研究结果揭示了CaMKIIγ在调节肺癌细胞干性和致瘤性中的关键作用,并为TICs提供了一个有前景的治疗靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/d65f9e39a7ca/oncotarget-06-16069-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/5e3232a0dca5/oncotarget-06-16069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/7d0365e92306/oncotarget-06-16069-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/42ae14c91ab1/oncotarget-06-16069-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/9c8ec3c62270/oncotarget-06-16069-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/b44cbbc38b7f/oncotarget-06-16069-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/4ae8cad913c6/oncotarget-06-16069-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/b33d9a13347b/oncotarget-06-16069-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/d65f9e39a7ca/oncotarget-06-16069-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/5e3232a0dca5/oncotarget-06-16069-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/7d0365e92306/oncotarget-06-16069-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/42ae14c91ab1/oncotarget-06-16069-g003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/9c8ec3c62270/oncotarget-06-16069-g004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/b44cbbc38b7f/oncotarget-06-16069-g005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/4ae8cad913c6/oncotarget-06-16069-g006a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/b33d9a13347b/oncotarget-06-16069-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/29f4/4599257/d65f9e39a7ca/oncotarget-06-16069-g008.jpg

相似文献

1
Ca2+/calmodulin-dependent protein kinase IIγ enhances stem-like traits and tumorigenicity of lung cancer cells.钙离子/钙调蛋白依赖性蛋白激酶IIγ增强肺癌细胞的干细胞样特性和致瘤性。
Oncotarget. 2015 Jun 30;6(18):16069-83. doi: 10.18632/oncotarget.3866.
2
miR-942 promotes cancer stem cell-like traits in esophageal squamous cell carcinoma through activation of Wnt/β-catenin signalling pathway.微小RNA-942通过激活Wnt/β-连环蛋白信号通路促进食管鳞状细胞癌中癌症干细胞样特性。
Oncotarget. 2015 May 10;6(13):10964-77. doi: 10.18632/oncotarget.3696.
3
Construction and application of a lung cancer stem cell model: antitumor drug screening and molecular mechanism of the inhibitory effects of sanguinarine.肺癌干细胞模型的构建与应用:抗肿瘤药物筛选及血根碱抑制作用的分子机制
Tumour Biol. 2016 Oct;37(10):13871-13883. doi: 10.1007/s13277-016-5152-5. Epub 2016 Aug 2.
4
miRNA-regulated delivery of lincRNA-p21 suppresses β-catenin signaling and tumorigenicity of colorectal cancer stem cells.微小RNA调控的长链非编码RNA-p21传递可抑制β-连环蛋白信号通路及结直肠癌干细胞的致瘤性。
Oncotarget. 2015 Nov 10;6(35):37852-70. doi: 10.18632/oncotarget.5635.
5
Tumorigenic and metastatic activity of human thyroid cancer stem cells.人甲状腺癌细胞癌干细胞的致瘤性和转移性活性。
Cancer Res. 2010 Nov 1;70(21):8874-85. doi: 10.1158/0008-5472.CAN-10-1994. Epub 2010 Oct 19.
6
Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells.Notch和Wnt/β-连环蛋白信号通路在激活肝癌干细胞中发挥重要作用。
Oncotarget. 2016 Feb 2;7(5):5754-68. doi: 10.18632/oncotarget.6805.
7
Histone deacetylase 1/Sp1/microRNA-200b signaling accounts for maintenance of cancer stem-like cells in human lung adenocarcinoma.组蛋白去乙酰化酶1/Sp1/微小RNA-200b信号通路参与维持人肺腺癌中癌症干细胞样细胞的特性。
PLoS One. 2014 Oct 3;9(10):e109578. doi: 10.1371/journal.pone.0109578. eCollection 2014.
8
High levels of SIRT1 expression enhance tumorigenesis and associate with a poor prognosis of colorectal carcinoma patients.高水平的SIRT1表达增强肿瘤发生,并与结直肠癌患者的不良预后相关。
Sci Rep. 2014 Dec 15;4:7481. doi: 10.1038/srep07481.
9
A CD90(+) tumor-initiating cell population with an aggressive signature and metastatic capacity in esophageal cancer.食管癌中具有侵袭性特征和转移能力的 CD90(+)肿瘤起始细胞群体。
Cancer Res. 2013 Apr 1;73(7):2322-32. doi: 10.1158/0008-5472.CAN-12-2991. Epub 2013 Feb 4.
10
MiR-1181 inhibits stem cell-like phenotypes and suppresses SOX2 and STAT3 in human pancreatic cancer.miR-1181 抑制人胰腺癌细胞中的干细胞样表型并抑制 SOX2 和 STAT3。
Cancer Lett. 2015 Jan 28;356(2 Pt B):962-70. doi: 10.1016/j.canlet.2014.11.007. Epub 2014 Nov 10.

引用本文的文献

1
CAMKIIδ Reinforces Lipid Metabolism and Promotes the Development of B Cell Lymphoma.钙/钙调蛋白依赖性蛋白激酶IIδ增强脂质代谢并促进B细胞淋巴瘤的发展。
Adv Sci (Weinh). 2025 Mar;12(10):e2409513. doi: 10.1002/advs.202409513. Epub 2025 Jan 22.
2
Network Pharmacology and Molecular Docking Study on the Mechanism of the Therapeutic Effect of Strychni Semen in NSCLC.马钱子治疗非小细胞肺癌作用机制的网络药理学及分子对接研究
Biol Proced Online. 2024 Dec 31;26(1):33. doi: 10.1186/s12575-024-00259-w.
3
Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem Cells by Blocking the STAT3 Signaling Pathway.

本文引用的文献

1
First-line crizotinib versus chemotherapy in ALK-positive lung cancer.克唑替尼对比化疗用于治疗 ALK 阳性肺癌。
N Engl J Med. 2014 Dec 4;371(23):2167-77. doi: 10.1056/NEJMoa1408440.
2
Inhibition of pluripotency networks by the Rb tumor suppressor restricts reprogramming and tumorigenesis.Rb肿瘤抑制因子对多能性网络的抑制作用限制了重编程和肿瘤发生。
Cell Stem Cell. 2015 Jan 8;16(1):39-50. doi: 10.1016/j.stem.2014.10.019. Epub 2014 Nov 13.
3
Akt-dependent metabolic reprogramming regulates tumor cell histone acetylation.Akt 依赖的代谢重编程调节肿瘤细胞组蛋白乙酰化。
PRMT1 抑制通过阻断 STAT3 信号通路抑制 U87MG 衍生的神经胶质瘤干细胞的生长。
Int J Mol Sci. 2024 Mar 3;25(5):2950. doi: 10.3390/ijms25052950.
4
Pharmacological profiling of a berbamine derivative for lymphoma treatment.贝母素甲衍生物治疗淋巴瘤的药理学特征分析。
Blood Adv. 2024 Jan 23;8(2):309-323. doi: 10.1182/bloodadvances.2023010873.
5
TRPM1 promotes tumor progression in acral melanoma by activating the Ca/CaMKIIδ/AKT pathway.TRPM1 通过激活 Ca/CaMKIIδ/AKT 通路促进肢端黑色素瘤的肿瘤进展。
J Adv Res. 2023 Jan;43:45-57. doi: 10.1016/j.jare.2022.03.005. Epub 2022 Mar 12.
6
Synergistic Anticancer Effect of a Combination of Berbamine and Arcyriaflavin A against Glioblastoma Stem-like Cells.贝母素甲和石耳黄素 A 联合对神经胶质瘤干细胞的协同抗癌作用。
Molecules. 2022 Nov 17;27(22):7968. doi: 10.3390/molecules27227968.
7
Review on the Therapeutic Potential of Curcumin and its Derivatives on Glioma Biology.姜黄素及其衍生物在神经胶质瘤生物学治疗潜力的研究进展。
Neurochem Res. 2022 Oct;47(10):2936-2953. doi: 10.1007/s11064-022-03666-1. Epub 2022 Jul 5.
8
Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells.发现一种针对胶质母细胞瘤干细胞样细胞的新型CaMKII靶向合成致死疗法。
Cancers (Basel). 2022 Mar 4;14(5):1315. doi: 10.3390/cancers14051315.
9
Advances in Intracellular Calcium Signaling Reveal Untapped Targets for Cancer Therapy.细胞内钙信号传导的进展揭示了癌症治疗中尚未开发的靶点。
Biomedicines. 2021 Aug 24;9(9):1077. doi: 10.3390/biomedicines9091077.
10
CAMK2G is identified as a novel therapeutic target for myelofibrosis.CAMK2G 被鉴定为骨髓纤维化的一个新的治疗靶点。
Blood Adv. 2022 Mar 8;6(5):1585-1597. doi: 10.1182/bloodadvances.2020003303.
Cell Metab. 2014 Aug 5;20(2):306-319. doi: 10.1016/j.cmet.2014.06.004. Epub 2014 Jul 3.
4
An integrin β₃-KRAS-RalB complex drives tumour stemness and resistance to EGFR inhibition.整合素 β₃-KRAS-RalB 复合物驱动肿瘤干细胞特性和对 EGFR 抑制的抗性。
Nat Cell Biol. 2014 May;16(5):457-68. doi: 10.1038/ncb2953. Epub 2014 Apr 20.
5
The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.PRKCI 和 SOX2 癌基因共扩增,并合作激活肺鳞癌中的 Hedgehog 信号通路。
Cancer Cell. 2014 Feb 10;25(2):139-51. doi: 10.1016/j.ccr.2014.01.008.
6
Cancer statistics, 2014.癌症统计数据,2014 年。
CA Cancer J Clin. 2014 Jan-Feb;64(1):9-29. doi: 10.3322/caac.21208. Epub 2014 Jan 7.
7
RETRACTED: Ca(2+)/calmodulin-dependent protein kinase IIγ, a critical mediator of the NF-κB network, is a novel therapeutic target in non-small cell lung cancer.撤回:钙调蛋白依赖性蛋白激酶 IIγ,NF-κB 网络的关键介质,是非小细胞肺癌的一个新的治疗靶点。
Cancer Lett. 2014 Mar 1;344(1):119-128. doi: 10.1016/j.canlet.2013.10.022. Epub 2013 Nov 1.
8
Tumour heterogeneity and cancer cell plasticity.肿瘤异质性和癌细胞可塑性。
Nature. 2013 Sep 19;501(7467):328-37. doi: 10.1038/nature12624.
9
Berbamine inhibits the growth of liver cancer cells and cancer-initiating cells by targeting Ca²⁺/calmodulin-dependent protein kinase II.小檗胺通过靶向钙调蛋白依赖性蛋白激酶 II 抑制肝癌细胞和癌起始细胞的生长。
Mol Cancer Ther. 2013 Oct;12(10):2067-77. doi: 10.1158/1535-7163.MCT-13-0314. Epub 2013 Aug 19.
10
The stem cell markers Oct4A, Nanog and c-Myc are expressed in ascites cells and tumor tissue of ovarian cancer patients.干细胞标志物 Oct4A、Nanog 和 c-Myc 在卵巢癌患者的腹水细胞和肿瘤组织中表达。
Cell Oncol (Dordr). 2013 Oct;36(5):363-74. doi: 10.1007/s13402-013-0142-8. Epub 2013 Aug 9.